The introduction of nicotinamide as being a nicotine substitute in e-cigarette and smokeless products and solutions represents a big regulatory challenge for the FDA. Nicotinamide doesn't have nicotinic receptor agonist activity and is understood to work as a sedative at substantial dosages6. Th